BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.4322
+0.0024 (0.56%)
At close: May 12, 2025, 4:00 PM
0.4500
+0.0178 (4.12%)
After-hours: May 12, 2025, 7:51 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $25.24 million as of May 12, 2025. Its market cap has decreased by -77.67% in one year.
Market Cap
25.24M
Enterprise Value
-6.57M
1-Year Change
-77.67%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $25.24M, a decrease of -95.63%. That is a compound annual growth rate of -50.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 25.10M | -26.83% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |